* Early investment and product characterization is key for biologics * What stages are best for product characterization? * Outsourced product characterization services
Traditional planar culture formats are being superceded by microcarriers for large-scale cell therapy manufacturing.
Traditional planar culture formats are being superceded by microcarriers for large-scale cell therapy manufacturing.
Traditional planar culture formats are being superceded by microcarriers for large-scale cell therapy manufacturing.
Traditional planar culture formats are being superceded by microcarriers for large-scale cell therapy manufacturing.
How to strike a balance between site autonomy and global coordination.
*Monday, March 22, 2021 at 9am EDT| 1pm GMT | 2pm CET, Monday, March 22, 2021 at 2pm EDT| 1pm CDT | 11am PDT* High resolution is one of the key challenges in modern biopharmaceutical analysis. In this webinar learn the importance of considering the entire liquid chromatography (LC) system to gain optimum results and maximum resolution from your LC column. *On demand available after final airing until March 22, 2022*
Method choice is crucial to when seeking answers to biosimilar characterization questions.
The authors present a shift toward more integrated purification processes.
The authors present a shift toward more integrated purification processes.
The authors present a shift toward more integrated purification processes.
The authors present a shift toward more integrated purification processes.
The authors present a shift toward more integrated purification processes.
Perfusion processes can attractive for biologics drug manufacturing; however, obstacles remain.
Testing demonstrates an automated semi-continuous process strategy for viral inactivation with steps that mimic batch processing.
Short tandem repeat profiling is the most validated method to confirm cell line identity and avoid misidentified or cross-contaminated cell lines.
Short tandem repeat profiling is the most validated method to confirm cell line identity and avoid misidentified or cross-contaminated cell lines.
Continuous processing of 100 g of monoclonal antibody in 24 hours has been demonstrated using lab-scale equipment.
Short tandem repeat profiling is the most validated method to confirm cell line identity and avoid misidentified or cross-contaminated cell lines.
Newer classes of biotherapies will require innovations in processing technology.
USP experts share current perspectives on a risk-based approach to rapid sterility tests for short shelf-life products such as cell and gene therapies. Live: Wednesday, May 9, 2018 at 12 pm EDT | 11 am CDT | 9 am PDT / On Demand available after airing until May 9, 2019. Register free: http://www.biopharminternational.com/bp_w/rapid
A case study evaluates the performance, control of operations, productivity, and cost savings of a single-use system.